Michael R Hayden insider trades: AbCellera Biologics (ABCL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC





Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 24, 2026 | ABCL | ↑ Buy | 53,613 | $10.64 | $570K | Indirect | Aug 24, 2026 (0d) |
| Aug 12, 2026 | ABCL | ↑ Buy | 46,387 | $10.37 | $481K | Indirect | Aug 14, 2026 (2d) |
| May 1, 2025 | IONS | ↑ Buy | 15,000 | $31.86 | $478K | Direct | May 2, 2025 (1d) |
| Dec 23, 2024 | IONS | ↑ Buy | 5,000 | $36.22 | $181K | Direct | Dec 26, 2024 (3d) |
| Sep 22, 2023 | ABCL | ↑ Buy | 20,000 | $4.91 | $98K | Indirect | Sep 26, 2023 (4d) |
| Aug 8, 2023 | ABCL | ↑ Buy | 30,000 | $5.90 | $177K | Indirect | Aug 9, 2023 (1d) |
| Mar 28, 2023 | ETNB | ↑ Buy | 87,788 | $12.28 | $1.1M | Indirect | Mar 30, 2023 (2d) |
| Jun 22, 2021 | ABCL | ↓ Sell | 100,000 | $25.50 | $2.5M | Indirect | Jun 22, 2021 (0d) |
| Dec 15, 2020 | ABCL | ↑ Buy | 73,665 | $20.00 | $1.5M | By spouse | Dec 17, 2020 (2d) |
| Nov 11, 2019 | ETNB | ↑ Buy | 18,750 | $16.00 | $300K | Indirect | Nov 13, 2019 (2d) |
| Aug 14, 2017 | XENE | ↑ Buy | 15,000 | $2.75 | $41K | Direct | Aug 14, 2017 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABCL insiders
Open-market trades in the last 12 months
About Michael R Hayden's insider trades
Michael R Hayden is a director at AbCellera Biologics (ABCL). Since Aug 14, 2017, Michael has reported 10 open-market purchases worth $4.9M and 1 sale worth $2.5M on SEC Form 4. In the last 12 months: 2 buys ($1.1M).
Their filings also include grants and awards (31 filings), option exercises (20 filings), gifts (3 filings), conversions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABCL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.